TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

CytomX Therapeutics to Present at the Jefferies London Healthcare Conference

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Cytomx Therapeutics
CytomX Therapeutics to Present at the Jefferies London Healthcare Conference

CytomX Therapeutics, a clinical-stage oncology-focused biopharmaceutical company, announced upcoming presentations of its clinical-stage pipeline including CX-2051 and CX-801, with Phase 1 data updates expected in early 2026.

Insights
CTMX   positive

Company is progressing clinical trials, presenting new data, and has strategic collaborations with major pharmaceutical companies